Reciprocal association between insulin sensitivity and the haematocrit in man

European Journal of Clinical Investigation

Volumn 27, Issue 7, 1997, Pages 634-637

  Catalano, C ^a   Muscelli, E ^a   Natali, A ^a   Mazzoni, A ^b   Masoni, A ^a   Bernardini, B ^a   Seghieri, G ^c   Ferrannini, E ^a,d  

^a UNIVERSITY OF PISA   (Italy)

^b Blood Transfusion Centre   (Italy)

^c Spedali Riuniti   (Italy)

^d INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Blood viscosity; Cardiovascular risk; Haematocrit; Insulin resistance; NIDDM

Indexed keywords

ADULT; APHERESIS; ARTICLE; BLOOD VISCOSITY; CLINICAL ARTICLE; CONTROLLED STUDY; HEMATOCRIT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030878580     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1770714.x     Document Type: Article

References (23)

1. Ferrannini E, Stern MP. Primary insulin resistance: a risk syndrome. In: Leslie RDG, Robbins DC, eds. Diabetes.Clinical Science in Practice. Cambridge: Cambridge University Press, 1995:200-20.
2. Chabanel A, Chien S. Blood viscosity as a factor in human hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management 1st edn. New York: Raven Press, 1990;329-37.
3. Tibblin G, Bergentz S-E, Bjure J, Wilhelmsen L. Hematocrit, plasma protein, plasma volume, and viscosity in early hypertensive disease. Am Heart J 1966;72:165-76.
4. Cirillo M, Laurenzi M, Trevisan M, Stainler J. Hematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension 1992;20:319-26.
5. McDonough JR, Hames CG, Garrison GE, Stulb SC, Lichtman MA, Hefelfinger DC. The relationship of hematocrit to cardiovascular states of health in the negro and white population of Evans County, Georgia. J Chron Dis 1965;18:243-57.
6. Sorlie PD, Garcia-Palmieri MR, Costas R Jr, Havlik RJ. Hematocrit and the risk of coronary heart disease: The Puerto Rico Heart Health Program. Am Heart J 1981;101:456-61.
7. Carter C, Mc Gee D, Reed D, Yano K, Stemmermann G. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. Am Heart J 1983;105:674-79.
8. De Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 1990;81:107-17.
9. Wannamethee Goya S, Perry IJ, Shaper AG. Hematocrit and risk of NIDDM. Diabetes 1996;45:576-79.
10. Smith S, Julius S, Jamerson K, Amerena J, Schork N. Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh. Michigan. J Hypertens 1994;12:455-62.
11. Ferrannini E. The phenomenon of insulin resistance: its possible relevance to hypertensive disease. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. 1st edn. New York: Raven Press, 1990:2281-300.
12. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-33.
13. Ferrannini E, Smith JD, Cobelli C, Toffolo G, Pilo A, DeFronzo RA. Effect of insulin on the distribution and disposal of glucose in man. J Clin Invest 1985;76: 367-74.
14. Hume R. Prediction of lean body mass from height and weight. J Clin Pathol 1966;19: 389-91.
15. Del Prato S, Ferrannini E, DeFronzo RA. Evaluation of insulin sensitivity in man. In: Clarke WL, Larner J, Pohl SL, eds. Methods in Diabetes Research. II Clinical Methods. New York: John Wiley & Sons, 1986:35-76.
16. Reaven GM. A syndrome of resistance to insulin-stimulated glucose uptake (Syndrome X): definition and implications. Cardiovasc Risk Fact 1993;3:2-9.
17. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Eng J Med 1993;329:1988-92.
18. Gundersen HJG, Christensen N. Intravenous insulin causing loss of intravascular water and albumin and increased adrenergic nervous activity in diabetics. Diabetes 1977;26:551-7.
19. Mogensen CE, Christensen NJ, Gundersen HJG. The acute effect of insulin on renal haemodynamics and protein excretion in diabetics. Diabetologia 1978;15:153-7.
20. Hilsted J, Christensen NJ, Larsen S. Effect of cathecolamines and insulin on plasma volume and intravascular mass of albumin in man. Clin Sci 1989;77:149-55.
21. Hilsted J, Christensen NJ. Dual effect of insulin on plasma volume and transcapillary albumin transport. Diabetologia 1992;35:99-103.
22. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-52.
23. Baron AD. Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Baillière's Clin Endocrinol Metab 1993;7:961-87.